Hyperthyroidism due to nodular goiter. Thyrotoxicosis with toxic multinodular goitre
Conditions
Interventions
Intervention 1: The control group did not cause any interference. Intervention 2: For groups of measuring the absorption of iodine, methimazole(Lughman Pharmaceutical company ) for 6 weeks with a dose
Treatment - Drugs
For groups of measuring the absorption of iodine, methimazole(Lughman Pharmaceutical company ) for 6 weeks with a dose of 15 mg daily is given.
Sponsors
Vice Chancellor for Research of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: consent to participate in this study; no previous drive; older than 20 years; patients who have severe thyrotoxicosis Exclusion criteria were: Allergies or contra-indications to methimazole; thyroid surgery; pregnancy and lactation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Radio Iodine Uptake. Timepoint: At baseline, 3 days off after a period of 6 weeks. Method of measurement: Nuclear medicine procedures. | — |
Secondary
| Measure | Time frame |
|---|---|
| TSH. Timepoint: Baseline, 3 months after administration of radioactive iodine. Method of measurement: Test.;FT4. Timepoint: Baseline, 3 months after administration of radioactive iodine. Method of measurement: Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Amir Bahrami
Tabriz University of Medical Sciences
Outcome results
None listed